Medical Devices Startups

Theragene Pharmaceuticals develops immunotherapy and gene therapy treatments for cancer and cardiovascular diseases using AAV technology. The company operates in the US and Asia, pursuing partnerships for product development and licensing.

1 investor

Theragraph develops a visualization tool that consolidates patient data into a unified, visual interface to help physicians better manage complex patient information and care. The platform serves healthcare providers seeking to streamline patient care coordination.

1 investor

Therakos develops THERAKOS Photopheresis, an FDA-approved extracorporeal photopheresis (ECP) system used to treat skin symptoms of cutaneous T-cell lymphoma (CTCL) unresponsive to other treatments. It provides medical devices and associated drug therapy for clinicians treating CTCL patients.

1 investor

TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model. It creates and spins out privately funded medical device companies and has conducted clinical research in the United States, Europe, and South America.

1 investor

Theratome Bio is a regenerative medicine company using artificial intelligence to develop secretome-based therapeutics that address tissue repair and disease. The company focuses on organ transplant preservation and dry eye disease treatments.

1 investor

THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.

1 investor

Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.

1 investor

TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating). Its patent-protected technology aims to improve tolerability over existing treatments while maintaining efficacy.

1 investor

Thermology Health develops thermal imaging technology for diagnostic healthcare applications, delivering medical-grade temperature measurement accuracy to enable new clinical diagnostic and prognostic capabilities. The company spun out from the UK's National Physical Laboratory and creates proprietary imaging platforms and diagnostic algorithms for health applications.

1 investor

ThermoTek develops medical cooling and compression devices for post-surgical pain, edema, and DVT management, sold to patients and clinicians through a dealer network for orthopedic recovery and aesthetic procedures. It also produces chillers and thermal management systems for the scientific, laser, semiconductor, and military industries.

1 investor

ZOLL develops medical devices and software for defibrillation, cardiac monitoring, CPR feedback, supersaturated oxygen therapy, ventilation, temperature management, and sleep apnea diagnosis and treatment. Its products serve clinicians, EMS and fire professionals, and lay rescuers responding to critical cardiopulmonary conditions.

1 investor

Theseus Labs develops brain-computer interfaces and publishes neurotechnology research, while building software products for BCI data calibration and neuro-applications. The company also invests in and supports early-stage neurotech startups.

1 investor

Thestra is a University of Turku spin-out developing AI-based cancer diagnostics, including its EPLINEX biomarker assay that estimates tumor aggressiveness in head and neck squamous cell carcinoma (HNSCC) to help clinicians stratify patients to appropriate therapies. Its products serve clinicians and hospitals to guide treatment selection and prognosis.

1 investor

Theta Neurotech develops a non-invasive wearable EEG patch combined with an AI-powered mobile application designed to predict seizures. The system serves individuals with epilepsy and related neurological conditions.

1 investor

Think-Lands Co., Ltd. is a Japanese distributor of optical and RF/microwave components for telecommunications and industrial applications.

1 investor

Third Pole develops portable and miniaturized devices that generate inhaled nitric oxide on-demand for hospital and mobile treatment of severe cardiopulmonary diseases and lung infections. The company uses a patented technology inspired by natural lightning to produce nitric oxide safely and efficiently from air and electricity.

1 investor

Third Opinion matches patients with clinical trials to accelerate the development of treatments, particularly for patients with life-altering conditions who aren't responding to traditional therapies. The platform aims to make clinical trial participation more accessible and understandable for patients seeking alternative treatment options.

1 investor

Thirona develops AI software for lung disease diagnosis and treatment planning in hospitals. The company's technology enables precision medicine and personalized care for patients with common and rare lung conditions.

1 investor

Thomas Medical manufactures single-use medical devices and accessories for women's health, including catheters, procedure trays, uterine manipulators, and electrodes. Products are used in hospitals, surgery centers, fertility clinics, and gynecology practices globally.

1 investor

Thoracic Innovations is a medical device company that develops products using computer-aided design, rapid prototyping, and 3D printing, with a focus on the cardiothoracic and thoracic clinical area.

1 investor

Thrive Therapies Group provides therapy and support services for children with disabilities, offering results-driven services and intelligent tools to support development, well-being, and health outcomes.

1 investor

Thrombolex develops endovascular catheters using pharmaco-mechanical technology to treat arterial and venous thromboembolic (A+VTE) conditions by dissolving blood clots. Its FDA-cleared products are based on the BASHIR Endovascular Catheter platform for medical practitioners treating vascular disease.

1 investor

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). It is running a clinical study (Wave II) for people with Long QT Syndrome Type 2.

1 investor

Thunder Biotech is a cancer immunotherapy company developing MOTO-CAR treatments, which genetically engineer a patient's own macrophages into chimeric antigen receptor cells that target biomarkers on tumor cells to attack solid tumors. It focuses on immunotherapy for cancer patients with solid tumors.

1 investor